Abstract

Caprine mastitis represents a significant challenge to dairy goat production, adversely affecting animal health, milk quality, and farm profitability. Beyond its economic impact, the disease constitutes a relevant concern within the One Health framework, given the potential involvement of zoonotic pathogens, the dissemination of antimicrobial-resistant bacteria, and the risks associated with the consumption of raw or inadequately processed milk. Additionally, psychrotrophic microorganisms originating from mastitic milk may potentially compromise the technological quality of dairy products through the production of thermostable enzymes capable of degrading proteins and lipids. Therefore, effective control of caprine mastitis requires the implementation of integrated management strategies, continuous microbiological surveillance, and the prudent use of antimicrobials throughout the production chain.

Key words: Antibiotic resistance; Dairy goat farming; Foodborne pathogens; Subclinical infection.